Published: November 2024
Pen needles are specialized medical tools used in conjunction with injection pens to deliver medications subcutaneously. Over the years, the increased prevalence of chronic diseases such as diabetes and cardiovascular conditions that require regular, often lifelong, management through injections have increased the demand for pen needles. Designed to attach seamlessly to injection pens, pen needles enable users to self-administer their medications easily and safely from home. Additionally, these pen needles are developed in various sizes, with different needle lengths and gauges, to accommodate the unique needs of each patient based on factors such as body type, dosage, and comfort level.
It is worth noting that pen needles have significantly evolved, leading to advancements in the user-friendly treatment of chronic diseases. In 2007, the global pen needles market witnessed a milestone in diabetes treatment with safety pen needles being introduced for insulin delivery. This innovation paved the way for players engaged in pen needles market to develop more advanced pen needles, which have drastically improved patient survival rates and reduced mortality associated with diabetes. As the field continues to evolve, ongoing research and development efforts are focused on enhancing the capabilities of these needles. The integration of safety devices in these pen needles is particularly promising, as it holds the potential to revolutionize the treatment for chronic diseases thus fueling the overall pen needles market.
Roots Analysis has conducted an exhaustive study on advancements in pen needles, as part of our Needles Market report, featuring the current market landscape and future opportunity for the companies engaged in pen needles market, over a span of 11 years.
Interested in exploring innovative pen needles and their applications?
Pen needles are primarily associated with the administration of injectable medications, particularly for chronic diseases that require regular and precise dosing. Some of the specific diseases and conditions that necessitate the use of pen needles are as follows:
Individuals with type 1 diabetes rely on insulin therapy for survival due to the autoimmune destruction of insulin-producing beta cells in the pancreas. Insulin pens equipped with pen needles allow for convenient and accurate self-administration, which is crucial for maintaining glycemic control. In addition to this many patients with type 2 diabetes eventually require insulin therapy as their disease progresses. Pen needles facilitate easier insulin delivery, improving adherence to treatment regimens and enhancing patient satisfaction compared to traditional syringes.
Children and adults with growth hormone deficiency may require daily injections of synthetic growth hormone. Pen needles provide a less painful and more user-friendly method for administering these injections, leading to better patient compliance.
Therapies such as GLP-1 ireceptor therapy that are used to treat obesity and type 2 diabetes by enhancing insulin secretion and suppressing appetite are often delivered via pen injectors, making pen needles essential for effective treatment.
The following figure presents the advantages of pen needles:

Embecta is a spin out from Becton Dickinson. BD has developed various pen needle products such as BD ultra-fine micro pen needles, designed for minimal discomfort during insulin delivery and autoshield duo pen needles, featuring dual protection to prevent needlestick injuries. The company claims to be the largest manufacturer of insulin pen needles for diabetics, selling nearly 8 billion syringes and needle pens per year.
MTD, recently strengthened its position in the pen needles market with the acquisition of Ypsomed’s pen needles and blood glucose monitoring systems business segment. This acquisition which was closed in August 2024 took the total pen needle production capacity for the company to 2.5 billion pen needles annually.
Novo Nordisk is focused on developing novofine pen needles known for their superflow technology. These needles come in sizes like 4mm and 6mm, designed to enhance insulin flow and reduce injection force.
B.Braun claims to be one of the leading providers of pen needles. With omnican pen needles available in various lengths and gauges, catering to different patient needs, the company aims to provide quality of care to diabetic patients.
Owen Mumford is focused on developing safety needlesi to avoid the risk of needlestick injuries. Its ulticare safety pen needles are designed with safety features to protect against accidental needlestick injuries while ensuring accurate dosing. In March 2024, Owen Mumford Sdn Bhd, a subsidiary of Owen Mumford entered into a partnership with Duopharma Marketing Sdn Bhd for distribution of several diabetes and eye care products including pen needles in Malaysia.
In the rapidly evolving landscape of healthcare, the pen needles market holds immense potential for the future of chronic disease treatment. Technological advancements in pen needles are poised to revolutionize diabetes care by offering innovative needles with enhanced capabilities in patient safety, treatment and monitoring. One significant future perspective of pen needles lies in the realm of precise treatment at home healthcare settings. The shift towards home healthcare is a significant factor influencing the pen needles market.
As more patients opt for self-administration of medications at home, there is a growing preference for devices that are easy to use and require minimal training. This personalized approach of pen needles can lead to more effective interventions and better outcomes for diabetic patients. Moreover, safety equipped pen needles are anticipated to enhance patient compliance and reduce the risk of needlestick injuries. Additionally, the integration of smart technologies such as dose tracking, reminders, and mobile app connectivity have the potential to improve usability and adherence to medication regimens. Further, the pen needles market in various regions is also expected to witness substantial growth due to increasing healthcare expenditure and greater awareness of diabetes management.
The above presentation features trends related to the pen needles market, which we have highlighted in our report. If you're interested, you can download the Sample Report on needles market by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.
Sources